期刊文献+

还原型谷胱甘肽合用粉防己碱对帕金森病大鼠脑线粒体酶复合体I及活性氧的影响 被引量:2

The Effect of Glutathione and Tetrandrine on Mitochondrial Complex I and ROS of Brain in rats with Parkinson Disease
暂未订购
导出
摘要 目的观察还原型谷胱甘肽(GSH)合用粉防己碱(Tet)对帕金森病(PD)大鼠氧化应激水平的影响并探讨其作用机制。方法应用6-羟基多巴立体定向注射制作PD大鼠模型,将成功大鼠模型随机分为模型组、GSH组、GSH+Tet组、左旋多巴组,另设正常对照组,给药50d后测定鼠脑黑质线粒体酶复合体I活性及纹状体活性氧(R0S)含量。结果GSH+Tet对PD大鼠黑质线粒体酶复合体I有保护作用,GSH+Tet能明显降低PD大鼠纹状体活性氧(R0S)水平。结论GSH+Tet能减轻PD大鼠黑质及纹状体氧化应激损伤,并对线粒体呼吸链有一定保护作用。 Objective To observe the effects of glutathione(GSH) and tetrandrine(Tet) on nigral and striatum antioxidation system and mitochondrial complex I function in Parkinson disease (PD) model rat. Methods The PD rats model were established through stereotoxic microinjection of 6-OHDA.The model rats were randomly divided into 4 groups:model group, GSH group, GSH+ Tet group,L-dopa group and normal group. In each group drug treatment was given for 50 days. The activity of mitochondrial complexI in nigra and ROS in striatum were assayed after treat-ment. Results GSH+Tet group could increasely decrease the contents of ROS in striatum. GSH+ Tet could produce some protective effect on mitochondrial respiration chain. Conclusion GSH+Tet group could decrease the nigral and striatum oxidative stress in PD model rats,and produce some protective effect on mitochondria respiration chain.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2008年第2期177-180,共4页 Suzhou University Journal of Medical Science
基金 江苏省卫生厅科研指导性课题(Z200518)
关键词 还原型谷胱甘肽 粉防己碱 帕金森病 线粒体酶复合体I 活性氧 glutathione tetrandrine Parkinson disease mitochondrial complex I ROS
  • 相关文献

参考文献16

  • 1Anthony HV Schapira. Mitochondria in the etiology and pathogenesis of Parkinson's disease[J].The Lancet Neurology, 2008,7(1): 97-109.
  • 2包新民 舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.48-60.
  • 3丁正同,蒋雨平,任惠民,吕元.小鼠慢性暴露于百草枯对其脑线粒体呼吸链复合酶活性的影响[J].中国临床神经科学,2003,11(3):243-246. 被引量:7
  • 4Poewe W.The need for neuroprotective therapies in Parkinson's disease : a clinical perspective [J].Neurology, 2006,66(Suppl 4) : 2-9.
  • 5Khan FH, Sen T, Maiti AK, et al. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease [J]. Biochimica et Biophysica Acta,2005,1741(1-2):65-74.
  • 6Stokes AH, Lewis DY, I.ash LH, et al. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis[J]. Brain Research,2000,858(1): 1-8.
  • 7罗蔚锋,包仕尧,刘春风.还原型谷胱甘肽治疗帕金森病的临床研究[J].中国临床神经科学,2003,11(2):195-197. 被引量:15
  • 8Kannan R, Kuhlenhamp JF,Jeandidier E,et al. Evidence for carrier-mediated transport of glutathione across the blood brain barrier in the rat[J ]. Clinical Investigation, 1990,85(6):2009-2013.
  • 9Virgintino D, Robertson D, Errede M, et al. Expression of P-glycoprotein in human cerebral cortex microvessel [J].Histochemistry & cytochemistry, 2002, 50 (12):1671- 1676.
  • 10Seegers U,Potschka H,Loscher W.Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cell and brain parenchyma of amygdale-kindied rats[J].Epilepsia,2002,43(7):675 -684.

二级参考文献38

  • 1马爱梅,赵永波,陈英辉.P-糖蛋白对卡马西平和苯妥英钠通过大鼠血脑屏障影响的研究[J].中华神经科杂志,2005,38(7):438-441. 被引量:12
  • 2田晖,潘启超.双苄基异喹啉类生物碱粉防己碱与小檗胺逆转多药抗药性的比较研究[J].药学学报,1997,32(4):245-250. 被引量:24
  • 3徐叔云,卞如濂,陈修,主编.药理实验方法学.第二版.北京:人民卫生出版社,1991,440-447.
  • 4Mario E,Gabriella K,Peter R,et al.Oxidative stress free radical production in neural degeneration.Pharmac Ther,1994,63(1):77.
  • 5Sechi G,Deeden MG,Bua G.Reduced intravenous glutathione in the treatment ofearly Parkinsons disease.Progress in Neuropsy-chopharmacology and Biological Psychiatry,1996,20(8):1159.
  • 6Jenetzky B,Haucks,Youdim MBH,et al.Unaltered aconitase activity,but decreased complex I activity in substantia nigra pars compact of patients with Parkinson's disease.Neerosci Let,1994,169(1):126.
  • 7Fojo AT. Expression of multidrug resistance gene in human tumors and tissues[J]. Proc Natl Acad Sci USA, 1987,84(1):265.
  • 8Thiebaut F,Tsuruo T,Hamada H et al. Cellular localization of the multidrug-resistance gene P-glycoprotein in normal human tissue[J]. Proc Natl Acad Sci USA,1987,84(21):7735
  • 9Cordon-Cardo C, O'Brien J P, Casals D et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites[J]. Proc Natl Acad Sci USA,1989,86(2): 695.
  • 10Dun Y, Murakami H, Koyabu N et al. Dostribution of domperidone into the rat brain is increased by brain ischaemia or treatment with P-glycoprotein inhibitor verapamil[J]. J Pharm Pharmacol, 2002, 54(5):729.

共引文献101

同被引文献24

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部